Search for a command to run...
Charles River Laboratories International, Inc.
Diagnostics & Research
| Date | Politician | Asset | Action | Amount | Trade Price | 30D Price | 1M Return | Alpha | 1M Prediction |
|---|---|---|---|---|---|---|---|---|---|
May 15, 2026 |  Rohit KhannaD | Stock | Buy |
| $1,001 - $15,000 |
| $150.85 |
| $187.51 |
| +24.3% |
| +24.0% |
Mar 30, 2026 | Rohit KhannaD | Stock | Buy | $1,001 - $15,000 | $159.72 | $163.84 | +2.6% | -10.0% |
Feb 5, 2026 | Rohit KhannaD | Stock | Sell | $1,001 - $15,000 | $183.70 | $174.46 | -5.0% | -4.3% |
May 15, 2025 |  Rob BresnahanR | Stock | Sell | $1,001 - $15,000 | $138.89 | $149.45 | +7.6% | +6.5% |
May 12, 2025 |  Jefferson ShreveR | Stock | Sell | $15,001 - $50,000 | $143.08 | $151.11 | +5.6% | +2.5% |
May 8, 2025 | Jefferson ShreveR | Stock | Buy | $15,001 - $50,000 | $141.36 | $144.70 | +2.4% | -3.7% |
Apr 15, 2025 | Rohit KhannaD | Stock | Sell | $1,001 - $15,000 | $105.92 | $138.89 | +31.1% | +21.3% |
Apr 9, 2025 | Rohit KhannaD | Stock | Sell | $1,001 - $15,000 | $139.07 | $138.79 | -0.2% | -3.1% |
Apr 8, 2025 | Rob BresnahanR | Stock | Buy | $15,001 - $50,000 | $123.61 | $141.36 | +14.4% | +0.5% |
Mar 31, 2025 | Rohit KhannaD | Stock | Buy | $1,001 - $15,000 | $150.52 | $118.62 | -21.2% | -20.3% |
Mar 12, 2025 | Rohit KhannaD | Stock | Buy | $1,001 - $15,000 | $170.59 | $99.75 | -41.5% | -37.4% |
Feb 25, 2025 | Rohit KhannaD | Stock | Buy | $1,001 - $15,000 | $167.10 | $158.06 | -5.4% | -1.1% |
Feb 19, 2025 | Rohit KhannaD | Stock | Buy | $1,001 - $15,000 | $165.00 | $167.28 | +1.4% | +9.1% |
Jan 22, 2025 | Rohit KhannaD | Stock | Sell | $1,001 - $15,000 | $168.22 | $163.02 | -3.1% | -2.0% |
Jan 17, 2025 | Rohit KhannaD | Stock | Sell | $1,001 - $15,000 | $163.50 | $151.99 | -7.0% | -9.1% |
Jan 15, 2025 |  Julie JohnsonD | Stock | Buy | $1,001 - $15,000 | $173.91 | $151.99 | -12.6% | -15.5% |
Dec 16, 2024 | Rohit KhannaD | Stock | Sell | $1,001 - $15,000 | $190.07 | $173.91 | -8.5% | -6.5% |
Charles River Laboratories (CRL) is a Top-Ranked Value Stock: Should You Buy?
Drug Development Inputs & Services Stocks Q1 In Review: Charles River Laboratories (NYSE:CRL) Vs Peers
The 5 Most Interesting Analyst Questions From Charles River Laboratories’s Q1 Earnings Call
NeoGenomics and Charles River Laboratories Shares Plummet, What You Need To Know
[Latest] Global Transgenic Animals Market Size/Share Worth USD 7.89 Billion by 2035 at a 10.1% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)